Replies to post #188381 on Biotech Values

[DewDiligence]

The double-chin photo in this KYTH write-up from WSJ is awful:

http://www.wsj.com/articles/fda-panel-backs-kythera-double-chin-treatment-1425927177

[DewDiligence]

KYTH sells 1.99M* shares @$48.00—a 6% discount to Monday’s close:

http://finance.yahoo.com/news/kythera-biopharmaceuticals-announces-pricing-public-015234135.html

The share price is up sharply today, returning it to essentially where it was before the announcement of the financing.

*Assuming exercise of underwriter’s option.